States in the southern US have the greatest access to biologics and patients with psoriasis incurred fewer ambulatory and emergency visits, a new study found. The cross-sectional study used the 1996-2015 Medical Expenditure Panel Survey data to compare health care resource use and costs for patients with psoriasis among the 4 US census regions. Researchers found:
- The greatest access for biologics was in the South, followed by Northeast, West, and Midwest.
- Ambulatory visits per patient per year were highest in the West.
- The proportion of patients with ≥1 emergency department (ED) visits was highest in the Northeast.
- Compared with the remainder of the US, the West incurred the lowest total health care costs and lowest drug costs.
Nguyen KB, et al. Where you live matters: Regional differences in healthcare resource use for psoriasis in the United States. [Published online ahead of print October 10, 2019]. J Am Acad Dermatol. doi: 10.1016/j.jaad.2019.10.014.